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Short-term and subchronic vapor inhalation studies have shown that there are pronounced differences in
thetoxicological properties ofethyleneglycol monomethylether(EGME)andpropyleneglycol monomethyl
ether (PGME). Overexposure toEGME has resulted in adverse effectsontestes, bone marrow andlymphoid
tissues in laboratory animals. PGME does not affect these tissues, and instead, overexposure to PGME has
been associated with increases in liver weight and central nervous system depression.
EGME is primarily oxidized to methoxyacetic acid in male rats, while PGME apparently undergoes
O-demethylation to form propylene glycol. Since methoxyacetic acid has been shown to have the same
spectrum of toxicity as EGME in male rats, the observed differences in the toxicological properties of
EGME and PGME are thought to be due to the fact that the two materials are biotransformed via different
routes to different types of metabolites.
Introduction
Ethylene glycol monomethyl ether (EGME, 2-meth-
oxyethanol) is a primary alcohol while propylene glycol
monomethyl ether (PGME, 1-methoxy-2-propanol) is a
secondary alcohol. Despite the similarities in chemical
structure and physical properties (Table 1), recent
vapor inhalation studies discussed herein have shown
remarkable differences in the toxicological properties of
EGME and PGME (1-3). Moreover, the observed
differences in toxicity are apparently the result of
biotransformation of EGME and PGME via different
routes to different types of metabolites (4).
Table 1. Chemical structures and physical properties
of EGME and PGME.
EGME PGME
CH3-O-CH2-CH2-OH CH3-O-CH2-CH(CH:3)-OH
2-methoxyethanol 1-methoxy-2-propanol
Molecular weight 76.1 90.1
Boiling point, °C 124.6 120.1
Specific gravity 0.963 0.919
Vapor pressure,
mm Hg at 25°C 9.5 12.5
*Dow Chemical U.S.A., Health and Environmental Sciences U.S.A.,
Tbxicology Research Laboratory, Midland, MI 48640.
EGME and PGME Subchronic
Vapor Inhalation Studies
The subchronic vapor inhalation studies were con-
ductedusingmale and femalerats andrabbits. Sprague-
Dawley rats and New Zealand White rabbits were used
in the EGME study, while Fischer 344 rats and New
Zealand White rabbits were used in the PGME study.
The animals were exposed 6 hr/day, 5 days/week, for a
total of 13 weeks. The exposure concentrations for the
EGME study were 0, 30, 100 and 300 ppm; the PGME
exposure concentrations (0, 300, 1000 and 3000 ppm)
were 10-fold higher than for EGME. The criteria of
response included daily observations for signs of tox-
icity, weekly body weight measurements, hematology
analyses, clinical chemistry analyses, urinalyses (rats),
and organ weights, we well as gross and histopathologic
examinations.
Two male and two female rabbits exposed to 300 ppm
EGME, and two female rabbits exposed to 100 ppm
EGME died or were sacrificed moribund during the
course of the study. One of the two rabbits in the 100
ppm group was sacrificed moribund with an inner ear
infectionunrelatedtoexposure. Otherwise, therelation-
ship of the deaths to EGME exposure was uncertain.
Hematologic analyses revealed decreases in hemoglo-
bin concentration, packed cell volume, white blood cell
counts, and platelet counts, as well as a tendencyMILLER ET AL.
toward decreased red blood cell counts in both male and
female rats exposed to 300 ppm EGME (Table 2). There
were no significant hematologic changes in either male
or female rats in the 100 ppm or 30 ppm groups.
Male and female rabbits exposed to 300 ppm EGME
had the same sort ofhematologic changes as occurred in
rats, including significant decreases in red blood cell
counts (Table 3). There were no hematologic effects in
rabbits in the 100 or 30 ppm groups.
Body weights of male and female rats in the 300 ppm
group, as well as female rats in the 100 ppm group, were
significantly lower than for controls as a result of
exposure to EGME (Table 4). Relative thymus weights
of male and female rats, and relative testes weights of
males in the 300 ppm group were significantly lower
than for controls. Relative liver weights ofrats were not
appreciably altered by exposure to concentrations of
EGME as high as 300 ppm.
Relative thymus and testes weights of rabbits ex-
posed to 300 ppm EGME were significantly lower than
for controls (Table 5), as also occurred for rats. Relative
testes weights of rabbits in the 100 ppm group also
tended to be lower than for controls on the average.
Body weights and relative liver weights ofrabbits were
not statistically significantly altered by the EGME
exposures, although the body weights of rabbits in the
300 ppm group tended on the average to be lower than
controls.
Histopathologic observations for rats in the 300 ppm
EGME group included: bilateral, severe to moderate
degeneration of the testicular germinal epithelium;
reduced numbers ofspermatozoa; increased degenerat-
ing spermatozoa; slight reduction in prostatic secretory
material; and decreased thymic cortical lymphocytes.
There were no treatment-related histopathologic obser-
vations in rats exposed to 100 ppm or 30 ppm EGME.
Table 2. Hematology analyses for rats exposed to EGME.
Hematologic parameter
Sex EGME, ppm RBC Hgb PCV WBC Platlets
Male 0 8.69 ± 0.68 17.3 ± 1.0 52.1 ± 2.8 13.7 ± 5.0 1381 ± 140
30 8.70 ± 0.52 16.4 ± 0.6 49.4 ± 2.3 10.5 ± 2.4 1316 ± 179
100 8.83 + 0.20 16.8 ± 0.5 50.9 ± 1.8 11.8 ± 2.5 1336 ± 127
300 8.48 ± 0.52 15.5 ± 1.2" 46.5 ± 3.6* 8.6 ± 2.8* 953 ± 120*
Female 0 7.86 ± 0.38 16.1 ± 0.6 48.8 ± 1.9 9.6 ± 2.8 1317 ± 156
30 8.12 + 0.50 16.3 ± 0.6 49.9 ± 2.0 8.3 ± 1.9 1402 ± 132
100 8.14 ± 0.15 16.2 ± 0.4 49.0 ± 1.3 9.0 ± 2.4 1345 ± 125
300 7.66 ± 0.38 14.7 ± 0.6* 44.6 ± 1.9* 4.5 ± 1.8* 1166 ± 148*
*Statistically significant deviation from control group mean using Dunnett's test.
Table 3. Hematology analyses for rabbits exposed to EGME.
Hematologic parameter
Sex EGME, ppm RBC Hgb PCV WBC Platlets
Male 0 5.98 ± 0.37 14.6 ± 0.9 42.8 ± 2.7 8.5 ± 1.6 759 ± 153
30 5.89 ± 0.24 14.3 ± 0.6 41.9 ± 1.5 9.9 ± 1.3 732 ± 103
100 5.48 ± 0.24 13.4 ± 0.5 39.0 ± 1.7 8.7 ± 1.5 702 ± 88
300 4.02 ± 0.73* 9.6 ± 1.6* 28.1 ± 5.0* 4.1 ± 0.9* 469 ± 187*
Female 0 5.39 ± 0.49 12.7 ± 1.6 37.8 ± 2.4 7.7 ± 2.7 787 ± 103
30 5.60 ± 0.25 12.8 ± 0.3 38.5 ± 1.5 6.8 ± 1.1 883 ± 255
100 4.86 ± 0.52 11.5 ± 0.9 34.3 ± 2.9 8.3 ± 2.6 924 ± 409
300 3.54 ± 0.31 8.5 ± 0.8* 25.0 ± 2.2* 3.5 ± 1.2* 687 ± 236
Statistically significant deviation from control group mean using Dunnett's test.
Table 4. Terminal body weights and organ weights of rats exposed to EGME.
Sex EGME, ppm Body wt, g Liver, g/100 Thymus, g/100 Testes, g/100
Male 0 487 ± 53 2.47 ± 0.23 0.07 ± 0.01 0.71 ± 0.13
30 465 ± 53 2.48 ± 0.13 0.08 ± 0.02 0.62 ± 0.17
100 501 ± 30 2.36 ± 0.17 0.07 ± 0.01 0.71 ± 0.05
300 432 ± 31* 2.31 ± 0.08 0.04 ± 0.01* 0.33 ± 0.08*
Female 0 277 ± 23 2.61 ± 0.10 0.14 ± 0.03
30 264 ± 28 2.68 ± 0.11 0.13 ± 0.02
100 247 ± 21* 2.62 ± 0.17 0.13 ± 0.03
300 229 ± 20* 2.68 ± 0.23 0.06 ± 0.01*
*Statistically significant deviation from control group mean using Dunnett's test.
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There was bilateral, severe degeneration oftesticular
germinal epithelium, as well as lymphoid tissue atrophy
and decreased liver glycogen in rabbits in the 300 ppm
group. Similar but less severe testicular changes were
found in three of five rabbits exposed to 100 ppm
EGME, and slight degenerative changes were found in
one of five rabbits in the 30 ppm group. A follow-up
study (Chemical Manufacturers Association, unpub-
lished data) with larger numbers of animals resulted in
no testicular effects in rabbits exposed to 3, 10 or 30
ppm EGME vapors for 13 weeks. Hence, 30 ppm is a
virtual no-adverse-effect level for testicular effects in
rabbits.
Although histopathologic effects on the bone marrow
were not apparent in rats or rabbits exposed to EGME
for 13-weeks, a marked decrease in bone marrow
cellularity was found in animals exposed to 1000 ppm for
2 weeks (1). Hence, the observed hematologic changes
were presumably the result of a primary effect on bone
marrow.
PGME Subchronic Vapor Inhalation
Study
There were no mortalities of rats prior to scheduled
sacrifice. One male rabbit in the 3000 ppm group was
sacrificed after 9 weeks ofstudy afterbeingaccidentally
injured while weighing.
Rats and rabbits in the 3000 ppm group appeared to
be sedated, particularly during the first few days of
exposure. Rats were hypothermic following the first few
exposures; these sedative effects were no longer appar-
ent after approximately the first 2 weeks of exposure.
There were notreatment-related hematologic changes
in male or female rats (Table 6). White cell counts of
female rats in the 300 ppm group were higher than
controls, while white cell counts of females in the 3000
ppm group were lower than controls. These apparent
differences in white cell counts were thought to be
sporadic occurrences unrelated to exposure in view of
the absence of a dose-response relationship.
Table 5. Terminal body weights and organ weights of rabbits exposed to EGME.
Sex EGME, ppm Body wt, g Liver, g/100 Thymus, g/100 Testes, g/100
Male 0 4103 ± 528 2.38 ± 0.30 0.16 + 0.03 0.14 ± 0.03
30 4255 ± 288 2.44 ± 0.47 0.16 ± 0.02 0.13 ± 0.04
100 4036 ± 539 2.25 ± 0.35 0.14 ± 0.02 0.10 ± 0.03
300 3745 ± 369 2.57 ± 0.30 0.09 ± 0.03* 0.04 ± 0.01*
Female 0 4511 ± 676 2.32 ± 0.33 0.18 + 0.06
30 4768 ± 435 2.57 ± 0.15 0.17 ± 0.04
100 3810 ± 410 2.20 ± 0.58 0.16 ± 0.01
300 3945 ± 218 2.45 ± 0.77 0.09 ± 0.01*
*Statistically significant deviation from control group mean using Dunnett's test.
Table 6. Hematology analyses for rats exposed to PGME.
Hematologic parameter
Sex PGME, ppm RBC Hgb PCV WBC Platlets
Male 0 8.51 ± 0.32 16.7 ± 0.7 45.9 ± 1.6 7.7 ± 0.6 892 ± 42
300 8.37 ± 0.31 16.7 ± 0.6 45.2 ± 2.0 7.5 ± 0.8 866 ± 62
1000 8.37 ± 0.19 16.4 ± 0.4 44.9 ± 1.1 7.3 ± 1.1 845 ± 77
3000 8.43 ± 0.33 16.3 ± 0.6 45.2 ± 1.6 7.5 ± 0.5 937 ± 51
Female 0 7.75 ± 0.19 16.1 ± 0.3 44.8 ± 1.0 6.3 ± 0.6 913 ± 71
300 7.63 ± 0.28 15.9 ± 0.6 44.1 ± 1.5 7.4 ± 1.3* 930 ± 76
1000 7.72 ± 0.13 16.0 ± 0.3 44.4 ± 0.7 6.6 ± 0.9 955 ± 28
3000 7.93 ± 0.17 15.9 ± 0.4 44.5 ± 1.2 5.1 ± 0.5* 975 ± 42
Statistically significant deviation from control group mean using Dunnett's test.
Table 7. Hematology analyses for rabbits exposed to PGME.
Hematologic parameter
Sex PGME, ppm RBC Hgb PCV WBC Platlets
Male 0 6.62 ± 0.35 14.1 ± 0.9 45.9 ± 3.1 8.5 ± 1.2 359 ± 33
300 6.34 ± 0.34 14.1 ± 0.8 46.5 ± 2.5 9.6 ± 1.8 400 ± 76
1000 6.00 ± 0.58 13.8 1.0 45.0 ± 3.3 8.2 ± 1.3 415 ± 52
3000 6.48 ± 0.23 14.4 ± 0.5 47.8 ± 1.5 8.2 ± 1.7 412 ± 61
Female 0 5.96 ± 0.37 13.4 ± 0.6 43.9 ± 2.0 8.1 ± 1.7 299 ± 94
300 6.29 ± 0.30 14.0 ± 0.4 46.2 ± 1.6 8.0 ± 1.8 343 ± 63
1000 5.56 ± 0.34 12.9 ± 0.6 42.0 ± 2.2 7.9 ± 2.2 355 _68
3000 5.79 ± 0.28 13.4 ± 0.5 43.1 ± 1.5 7.6 ± 2.7 279 ± 79
235MILLER ET AL.
Table 8. Terminal body weight and organ weights of rats exposed to PGME.
Sex PGME, ppm Body wt, g Liver, g/100 Thymus, g/100 Testes, g/100
Male 0 301 ± 13 2.54 ± 0.11 0.08 ± 0.01 1.03 + 0.04
300 293 + 8 2.49 ± 0.09 0.08 + 0.02 1.04 ± 0.05
1000 299 ± 14 2.50 ± 0.08 0.09 + 0.01 1.03 ± 0.09
3000 295 ± 12 2.70 ± 0.20 0.07 + 0.01 1.06 0.O05
Female 0 165 ± 10 2.45 ± 0.15 0.13 + 0.03
300 169 ± 9 2.49 ± 0.17 0.14 + 0.03
1000 169 ± 8 2.53 ± 0.09 0.13 + 0.02
3000 167 ± 5 2.63 ± 0.07* 0.12 + 0.01
Statistically significant deviation from control group mean using Dunnett's test.
Table 9. Terminal body weight and organ weights of rabbits
exposed to PGME.
PGME, Body wt, Liver, Testes,
Sex ppm g g/100 g/100
Male 0 4180 ± 609 2.50 ± 0.43 0.13 ± 0.02
300 4085 ± 451 2.18 ± 0.53 0.16 ± 0.03
1000 4252 ± 483 2.70 ± 0.61 0.15 ± 0.03
3000 3913 ± 161 2.64 ± 0.48 0.14 ± 0.02
Female 0 4678 ± 375 2.50 ± 0.34
300 4606 ± 316 2.60 ± 0.30
1000 4574 ± 322 2.54 ± 0.57
3000 4612 ± 623 2.62 ± 0.34
There were no hematologic changes in male or female
rabbits exposed to 300, 1000 or3000 ppm PGME vapors
(Table 7).
In sharp contrast to EGME, terminal body weights,
thymus weights and testes weights of rats were not
altered by exposure to PGME (Table 8). Liver weights
ofrats in the 3000 ppm group were higherthan controls.
However, there were no associated gross pathologic
changes or degenerative histopathologic changes in
livers of these animals.
Likewise, the terminal body weights, liver weights
and testes weights of rabbits were not altered by
exposure to PGME concentrations as high as 3000 ppm
(Table 9). Thymus weights of rabbits in the PGME
study were not measured.
Histopathologic examinations revealed indications of
hepatocellular swelling, but no degenerative changes, in
livers offemale rats in the 3000 ppm group. Otherwise,
there were no gross or histopathologic changes in either
male or female rats or rabbits exposed to 300, 1000 or
3000 ppm PGME.
Comparative Metabolism of EGME
and PGME
Male Fischer 344 rats, approximately 200 to 225 g,
were used for the metabolism studies. Three rats were
used per dose; each animal was given a single dose of
radiolabeled EGME orPGME by gavage. 14C-labeled as
well as 13C-labeled EGME and PGME were utilized.
EGME was labeled on either the 1 or 2 carbon; PGME
was labeled on the 1 carbon.
The animals were given a dose of approximately 1
mmole/kg or 8.7 mmole/kg ofEGME or PGME. For the
mass balance studies, each rat was given approximately
10 ,uCi of "4C-labeled EGME or PGME. Additional
groups of rats were given the high dose and approxi-
mately 100 ,Ci as well as 13C-labeled EGME or PGME
in order to facilitate isolation and identification ofurine
metabolites.
Immediately after dosing, each animal was placed in
a Roth-type metabolism cage for collection and analysis
of expired air and excreta. Urine was collected at dry
ice temperature at 12 hrintervals afterdosing. Airfrom
the metabolism cages was passed through charcoal and
CO2 traps; the charcoal traps were changed at 12-hr
intervals. The CO2 traps were changed at 4 hr intervals
for 12 hr and thereafter at 12-hr intervals. Feces were
collected at 24 hr intervals after dosing.
14C in urine, on charcoal and as 14CO2 in expired air
was quantitated by liquid scintillation spectrometry. 14C
in feces, tissues and carcass were quantitated as C02
by liquid scintillation spectrometry following combus-
tion of samples with a biological material oxidizer.
Urine samples were fractionated via an ion exclusion
chromatography system using AMINEX 50W x 4
(20-30 ,um) cation exchange resin (BIO-RAD Labora-
tories, Richmond, CA). Radioactivity in successive
0.5-mL fractions from the chromatography system were
quantitated by either liquid scintillation spectrometry
or by use of an in-line radioactivity detector. After
fractionation of urine samples, metabolites in urine
were identified by chemical ionization gas chromatog-
raphy-mass spectrometry utilizing aradio-gas detector.
After giving the low dose of [14C] EGME, 54.3% of
the 14C was recovered in urine within 48 hr (Table 10).
About 12% ofthe administered radioactivity was elimi-
nated as 14CO2 in expired air. Only 2.7% ofthe 14C was
excreted in feces, and recovery of 14C from charcoal
traps was minimal. Approximately 18% remained in the
carcass when animals were sacrificed 48 hrafterdosing.
Elimination ofthe high dose (8.7mmole/kg) ofEGME
was essentially the same as for the low dose (Table 10).
Urine was the major route of elimination of 14C; 63.2%
was excreted in urine within 48 hr after dosing. Again
about 12% was eliminated as 14CO2. Recovery from
charcoal was minimal, and only 2.6% was excreted in
feces; 12.6% remained in carcass after 48 hr.
In contrast elimination of 14C from animals given 1
mmole/kg [11C] PGME, on the other hand, was
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Table 10. Percent recovery during a 48-hr period after dosing.
Recovery, %
EGME PGME
1 mmole/kg 8.7 mmole/kg 1 mmole/kg 8.7 mmole/kg
Urine 54.3 ± 5.0 63.2 ± 3.9 11.2 ± 0.5 24.8 ± 2.0
Feces 2.7 ± 1.1 2.6 ± 0.9 0.9 ± 0.1 0.7 ± 0.2
Charcoal 0.4 ± 0.1 0.3 ± 0.9 3.0 ± 0.2 6.9 ± 0.5
CO2 11.8 ± 2.6 11.9 ± 2.0 63.0 + 1.0 56.5 ± 2.6
Carcass 18.3 ± 3.0 12.6 ± 1.1 9.2 ± 0.8 6.3 + 0.7
Skin 3.5 ± 0.4 3.6 ± 0.2 1.7 ± 0.1 1.7 ± 0.6
Wash 3.8 ± 0.3 1.2 ± 0.3 2.8 ± 0.1 0.6 ± 0.2
Total 94.8 ± 6.7 95.4 ± 0.7 91.8 ± 2.0 98.4 ± 1.3
aNumbers are mean ± SD values for n = 3 animals.
Table 11. Distribution of radioactivity 48 hr after
giving 14C-EGME.
Tissue/blood % of dose
Body 0.19 9.60 ± 0.8
Liver 0.66 1.57 ± 0.3
Kidney 0.35 0.20 ± 0.0
Blood 1.00 0.67 ± 0.2
Testes 0.19 0.13 ± 0.0
Fat 0.05
Thymus 0.30 0.02 ± 0.0
Spleen 0.29 0.03 ± 0.0
Table 12. Distribution of radioactivity 48 hr after
giving 14C-PGME.
Tissue/blood % of dose
Body 0.36 3.91 ± 0.13
Liver 2.33 1.40 ± 0.02
Kidney 1.11 0.14 ± 0.06
Blood 1.00 0.10 ± 0.02
Testes 0.34 0.08 ± 0.06
Fat 0.09
Thymus 1.19 0.02 ± 0.0
Spleen 1.12 0.03 ± 0.0
primarily via14CO2 (Table 10). Atotalof63% ofthe dose
was eliminated as 4CO2 within 48 hr after dosing; 33%
of the dose was eliminated during the first 4 hr and
another24%duringthe4to8hrinterval. Hence, thelow
dose of PGME was ver'y rapidly and extensively
metabolized. Excretion of 4C in urine ofanimals given
the low dose of PGME amounted to only 11.2% of the
dose. Excretion in feces was minimal, and only about
3% was recovered fromcharcoaltraps; 9.2%remained in
the carcass after 48 hr.
For the high dose of PGME, 56.5% of the adminis-
tered dose was eliminated as 14CO2 in 48 hr (Table 10).
In urine, 24.8% ofthe administered 14C was excreted in
48 hr. Excretion in feces was minimal, but almost 7% of
the high dose was recovered from charcoal. Only about
6% of the high dose of PGME remained in the carcass
after 48 hr. The percentage in urine was twice as great,
and the total percentage eliminated as 14CO2 was
slightly less after giving the high dose than after giving
the low dose. Also, the percentage remaining in carcass
was slightly less after giving the high dose than after
giving the low dose.
Of the radioactivity remaining in the various tissues
48 hr after giving 8.7 mmole/kg of [14C] EGME, the
blood had the greatest quantity per gram of tissue
(Table 11). The conspicuous target organs of EGME,
e.g., testes, thymus and spleen had lesser amounts of
14C than did the blood, and thus exhibited no apparent
tendency to accumulate the labeled test material or its
metabolites.
The liver had the greatest amount of14C per gram of
tissue 48 hr after giving the high dose ofPGME (Table
12). This observation is consistent with the fact that
absolute and relative liver weights are elevated in male
rats exposed tohighconcentrations ofPGME. However,
in view of the fact that the liver weight increases have
not been associated with gross or histopathologic
treatment-related changes, the significance of the high
concentration of 14C in the liver is unknown.
Fractionation ofurine collected during the first 12 hr
after giving 8.7 mmole/kg [14C] EGME revealed only
two distinct peaks ofradioactivity (Fig. 1). Peak B, the
B
Methoxyacetic
Acid
A
5.00 10.00 15.00 20.00 25.00
Radioactivity per ion exclusion chromatography fractions
FIGURE 1. Radioactivityperion-exclusionchromatographyfractions
forurine from male rats given an oral dose of["C] EGME. Peak A
accounted for less than 5% of the radiolabel in urine and was
not identified. Peak B accounted for approximately 95% of the
radiolabel in urine and was conclusively identified as methoxy-
acetic acid.
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R
PGME-
Gluc
Expired Air (10 20%)
A
PGME -
ISulfate
C Propylene Glycol
D
PGME
5.00 10.00 15.00 20.00 25.00
Radioactivity per ion exclusion chromatography fractions
FIGURE 2. Radioactivity perion-exclusionchromatography fractions
for urine from male rats given an oral dose of[14C] PGME. Peak A
represented 22%, Peak B 46%, Peak C 20%, and Peak D 12% ofthe
radioactivity in urine.
largest of the two peaks, accounted for approximately
95% ofthe 14C in the urine. This peak was identified by
GC-MS as methoxyacetic acid. Since 50 to 60% of the
administered 14C is eliminated in urine, oxidation of
EGME to methoxyacetic acid represents the major
route of biotransformation of EGME. Peak A, a minor
peak accounting forless than 5% ofthe activity in urine,
has not been conclusively identified.
Fractionation ofurine collected during the first 12 hr
after giving the high dose of PGME revealed four
distinct peaks of radioactivity (Fig. 2). Peak A had
about 22% ofthe 14C in urine, and wasidentified by FAB
mass spectrometry as a sulfate conjugate of PGME.
The largest of the peaks, Peak B, accounted for 46% of
the 14C in the urine and was identified as a glucuronide
conjugate of PGME. Peak C had 19 to 20% of the 14C
and was identified by GC-MS as 1,2-propandiol
(propylene glycol). However, the amount in urine is
probably only a small portion of the propylene glycol
actually formed in vivo from PGME, since propylene
glycol itself is known to be rapidly and extensively
metabolized, with only a small percentage being ex-
creted unchanged in urine (5). In fact, propylene glycol
is probably one of the intermediates for the large
fraction of the dose of PGME which is ultimately
eliminated as 14CO2. Peak D was identified by GC-MS
EGME PGME
CH3
CH2- OH CH3--CH2-CH-OH
Propylene
lucuronide alycol
Methoxy- Conjugate
Acetic / Sulfate
Acid Conjugate
Urine (50 60%) Urine (10 20%) Expired
Air (50 60%)
FIGURE 3. Comparative metabolism and disposition of EGME and
PGME in male rats.
as the parent compound (PGME), and represented 12%
of the radioactivity in urine.
Hence, the types ofurine metabolites for EGME and
PGME indicate that the two chemicals are biotrans-
formed via totally different routes (Fig. 3). EGME is
primarily oxidized to methoxyacetic acid, presumably
viathe alcohol dehydrogenase pathway. About 50to 60%
of the dose of EGME is excreted in urine as
methoxyacetic acid. Approximately 10 to 20% ofa dose
of EGME is much more extensively metabolized and
excreted as 14CO2 in the expired air.
PGME, on the other hand, is not a substrate for
alcohol dehydrogenase and instead apparently under-
goes 0-demethylation to formpropylene glycol, which in
turn is more extensively metabolized to CO2 and
excreted in expired air or eliminated unchanged in
urine. Although the parent compound (PGME) and its
sulfate and glucuronide conjugates as well as propylene
glycol are all present in urine, only about 10 to 20% of
the dose of PGME is eliminated via urine while 50 to
60% is eliminated as 14CO2.
Summary
Recent studies have shown that there are pronounced
differences in the toxicologic properties and potency of
EGME and PGME. EGME has a broad spectrum of
toxicity in adult laboratory animals, including bone
marrow effects with concomitant hematologic changes,
testicular effects which may culminate in infertility in
males, and lymphoid tissue atrophy. The tissues that
are conspicuously affected by EGME are those in which
there are high rates of cell division. However, not all
rapidly proliterating tissues are affected by EGME,
e.g., the intestinal epithelium. Therefore, factors other
than cell division are obviously important with regard
to the observed target organ specificity of EGME.
Although rabbits appear to be more sensitive than
either rats or mice with regard to certain effects, all
three species respond to EGME in qualitatively the
same manner.
In sharp contrast, exposure to high concentrations of
PGME results in central nervous system depression and
compensatory liver weight changes in laboratory
238
-TOXICITY AND METABOLISM OF EGME AND PGME 239
animals. The pronounced differences in the toxicologic
properties of EGME and PGME are believed to be due
to differences in routes of metabolism and types of
metabolites. Ethylene-series glycol ethers are primary
alcohols which are apparently metabolized via ADH in
the same manner as ethanol. The adverse effects of
EGME probably are due to its primary metabolite
methoxyacetic acid rather than the parent compound,
since methoxyacetic acid has the same spectrum of
toxicity as EGME in male rats (6). Propylene-series
glycol ethers are predominantly secondary alcohols, and
are biotransformed via microsomal enzymes to metabo-
lites such as propylene glycol which are relatively
innocuous.
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